EBMT 2024 | Optimizing preceding and consolidation therapies to prevent post-CAR-T relapse in B-ALL
Valentin Ortiz-Maldonado, MD, Hospital Clinic Barcelona, Barcelona, Spain, discusses strategies for preventing relapse in patients with B-cell acute lymphoblastic leukemia (B-ALL) in both the pre and post-CAR-T setting. Dr Ortiz-Maldonado mentions an analysis being conducted by the GoCART Coalition to gain data on the impact of preceding and consolidation regimens, to identify the optimal sequencing of therapies, and to select patients for which these regimens will be the most effective. This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Research grants: Fundación Española de Hematología y Hemoterapia
Travel grants: Kite, BMS, Novartis, Roche, Takeda & Janssen
Consultant or advisory fees: Kite, BMS, Novartis, Miltenyi, Janssen & Pfizer
Honoraria: Kite, BMS & Janssen
Employment: Hospital Clínic de Barcelona
